financetom
Business
financetom
/
Business
/
West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan
Jul 8, 2024 9:23 AM

12:10 PM EDT, 07/08/2024 (MT Newswires) -- West Pharmaceutical Services ( WST ) said Monday it amended its existing credit agreement to establish an incremental term loan in the stated principal amount of $130 million.

The loan was fully drawn at closing and matures July 2, 2027, according to a filing with the US Securities and Exchange Commission on Jul. 2.

West Pharmaceutical said it used the proceeds from the loan to help repay an outstanding term loan of about $80 million and to repay $53 million of its 3.82% series B senior notes due Jul. 5, according to the filing.

Price: 319.90, Change: -2.66, Percent Change: -0.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ASE Technology Reports 6.7% Growth in July Revenue
ASE Technology Reports 6.7% Growth in July Revenue
Aug 9, 2024
04:11 AM EDT, 08/09/2024 (MT Newswires) -- ASE Technology Holding Co ( ASX ) reported Friday revenue of $51.60 billion New Taiwan dollars ($1.59 billion) in July, up 6.7% from NT$48.35 billion a year earlier. Revenue for assembly, testing and material business increased 2.4% for the month to NT$27.44 billion, the company said. Price: 9.30, Change: +0.09, Percent Change: +0.98...
Zevra Therapeutics Prices $60 Million Stock Offering
Zevra Therapeutics Prices $60 Million Stock Offering
Aug 9, 2024
03:53 AM EDT, 08/09/2024 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) said it has priced a public offering of 9.2 million shares at $6.50 each for gross proceed of about $60 million. The offering is set to close on Aug. 12. The company said it has given underwriters a 30-day option to buy up to about 1.4 million additional...
--Valhi Maintains Quarterly Dividend At $0.08 Per Share, Payable Sept. 26, to Stockholders on Record on Sept. 6
--Valhi Maintains Quarterly Dividend At $0.08 Per Share, Payable Sept. 26, to Stockholders on Record on Sept. 6
Aug 9, 2024
03:28 AM EDT, 08/09/2024 (MT Newswires) -- Price: 17.43, Change: +0.52, Percent Change: +3.08 ...
Genmab's Interim Q2 Earnings, Revenue Climb; Increases 2024 Revenue Guidance
Genmab's Interim Q2 Earnings, Revenue Climb; Increases 2024 Revenue Guidance
Aug 9, 2024
04:06 AM EDT, 08/09/2024 (MT Newswires) -- Genmab A/S ( GMAB ) reported interim Q2 diluted earnings Thursday of 21.70 Danish kroner ($3.18), up from 20.28 Danish kroner a year earlier. Analysts polled by Capital IQ expected 22.79 Danish kroner. Revenue for the quarter ended June 30 was 5.4 billion Danish kroner, up from 4.17 billion Danish kroner a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved